ClinConnect ClinConnect Logo
Search / Trial NCT06806904

The Role of Ultrasonography in Labor in Predicting the Outcomes of Childbirth

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Jan 28, 2025

Trial Information

Current as of August 27, 2025

Recruiting

Keywords

Labor

ClinConnect Summary

This clinical trial is studying how ultrasound can help predict the outcomes of childbirth during labor. Specifically, researchers are looking at a technique called transabdominal ultrasound, which involves using a special device on the belly to measure an angle that may indicate how likely a woman is to have a successful vaginal delivery. They hope that by understanding certain ultrasound parameters during labor, doctors can better manage the delivery process and potentially increase the chances of a natural birth.

To participate in this trial, women must be at least 18 years old and have a single pregnancy that is full-term, meaning between 37 and 42 weeks. They should also be in the later stages of labor, with the cervix fully open. However, women with certain conditions, like problems with the placenta or previous uterine surgeries, cannot join. Participants will undergo ultrasound examinations during labor, and the information gathered may help improve childbirth experiences for future mothers.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Women aged \>= 18 years
  • Single pregnancy at term (37-42 gestational weeks)
  • Fetus in cephalic presentation and in expulsive period (complete cervical dilatation and premature sensation)
  • Acquisition of informed consent form
  • Exclusion Criteria:
  • Placenta previa
  • Uterine malformations
  • Previous uterine surgery
  • Cardiotocographic tracing (CTG) abnormalities
  • Any contraindication to vaginal delivery

About Irccs Azienda Ospedaliero Universitaria Di Bologna

IRCCS Azienda Ospedaliero-Universitaria di Bologna is a prestigious research and healthcare institution in Italy, renowned for its commitment to advancing medical science and patient care through innovative clinical research. As an IRCCS (Istituto di Ricovero e Cura a Carattere Scientifico), it integrates clinical practice with scientific research, facilitating the translation of laboratory findings into effective treatment strategies. The institution fosters a multidisciplinary approach, collaborating with various experts to conduct high-quality clinical trials aimed at improving health outcomes across a wide range of medical fields. With a strong emphasis on ethical standards and patient welfare, IRCCS Azienda Ospedaliero-Universitaria di Bologna plays a vital role in shaping the future of medicine through rigorous scientific inquiry and patient-centered care.

Locations

Bologna, , Italy

Patients applied

0 patients applied

Trial Officials

Aly Mohamed Alaaeldin Kamaleldin Aly Youssef, MD

Principal Investigator

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported